REQUEST A DEMO
Total
USD $0.00
Search more companies

Glaxosmithkline Lietuva UAB (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Glaxosmithkline Lietuva UAB Profile Updated: November 20, 2019
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English & Russian Download a sample report

Glaxosmithkline Lietuva UAB is based in Lithuania. The head office is in Vilnius. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on October 22, 2002. The company’s latest financial report indicates a net sales revenue drop of 59.86% in 2021. In, 2021, the company’s net profit margin increased by 6.29%.

Headquarters
Ukmerges g. 120
Vilnius; Vilnius county;

Contact Details: Purchase the Glaxosmithkline Lietuva UAB report to view the information.

Website: http://www.gsk.lt

Basic Information
Outstanding Shares:
Purchase the Glaxosmithkline Lietuva UAB report to view the information.
Registered Capital:
Purchase the Glaxosmithkline Lietuva UAB report to view the information.
Incorporation Date:
October 22, 2002
Key Executives
Purchase this report to view the information.
General Director
Company Performance
Created with Highstock 1.3.7Chart context menu2020Y2021Y
Net sales revenue
Net Profit (Loss) for the Period
Net Profit Margin
Financial values in the chart are available after Glaxosmithkline Lietuva UAB report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-59.86%
Total operating revenue
-59.86%
Net Profit (Loss) for the Period
147.78%
Total equity
3.11%
Net Profit Margin
6.29%
Return on Equity (ROE)
2.86%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?